- Home
- HOWL vs SRFM Comparison
HOWL vs SRFM Comparison
Compare HOWL & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- SRFM
- Stock Information
- Founded
- HOWL 2017
- SRFM 2011
- Country
- HOWL United States
- SRFM United States
- Employees
- HOWL N/A
- SRFM N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- SRFM Transportation Services
- Sector
- HOWL Health Care
- SRFM Consumer Discretionary
- Exchange
- HOWL Nasdaq
- SRFM Nasdaq
- Market Cap
- HOWL 53.8M
- SRFM 58.2M
- IPO Year
- HOWL 2021
- SRFM 2023
- Fundamental
- Price
- HOWL $1.21
- SRFM $1.95
- Analyst Decision
- HOWL Strong Buy
- SRFM Strong Buy
- Analyst Count
- HOWL 3
- SRFM 3
- Target Price
- HOWL $8.33
- SRFM $6.42
- AVG Volume (30 Days)
- HOWL 490.7K
- SRFM 778.7K
- Earning Date
- HOWL 08-07-2025
- SRFM 08-13-2025
- Dividend Yield
- HOWL N/A
- SRFM N/A
- EPS Growth
- HOWL N/A
- SRFM N/A
- EPS
- HOWL N/A
- SRFM N/A
- Revenue
- HOWL $1,143,000.00
- SRFM $112,307,000.00
- Revenue This Year
- HOWL N/A
- SRFM N/A
- Revenue Next Year
- HOWL N/A
- SRFM $62.23
- P/E Ratio
- HOWL N/A
- SRFM N/A
- Revenue Growth
- HOWL N/A
- SRFM 31.17
- 52 Week Low
- HOWL $0.60
- SRFM $0.90
- 52 Week High
- HOWL $4.18
- SRFM $6.72
- Technical
- Relative Strength Index (RSI)
- HOWL 51.44
- SRFM 39.50
- Support Level
- HOWL $1.19
- SRFM $1.91
- Resistance Level
- HOWL $1.35
- SRFM $2.48
- Average True Range (ATR)
- HOWL 0.13
- SRFM 0.24
- MACD
- HOWL -0.02
- SRFM -0.04
- Stochastic Oscillator
- HOWL 21.84
- SRFM 13.59
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.